"Patients benefit from easy access to oncologists and hematologists, the latest treatments, multidisciplinary care and pioneering clinical trials."

During the past decade, Marjorie Weinberg Cancer Center at Loyola-Gottlieb conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 2 clinical trials were completed, i.e. on average, 4.4% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 2 clinical trials were completed. i.e. 8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Marjorie Weinberg Cancer Center at Loyola-Gottlieb" #1 sponsor was "National Cancer Institute (NCI)" with 21 trials, followed by "SWOG Cancer Research Network" with 9 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored and "NRG Oncology" with 6 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marjorie Weinberg Cancer Center at Loyola-Gottlieb" #1 collaborator was "National Cancer Institute (NCI)" with 24 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Janssen, LP" with 1 trials as a collaborator, "NRG Oncology" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Marjorie Weinberg Cancer Center at Loyola-Gottlieb" are "Chronic Lymphocytic Leukemia" (3 trials), "Small Lymphocytic Lymphoma" (3 trials), "Stage IV Lung Cancer AJCC v8" (3 trials), "Stage IV Renal Cell Cancer AJCC v8" (3 trials) and "Bladder Adenocarcinoma" (2 trials). Many other conditions were trialed in "Marjorie Weinberg Cancer Center at Loyola-Gottlieb" in a lesser frequency.

Most popular intervention types in "Marjorie Weinberg Cancer Center at Loyola-Gottlieb" are "Drug" (33 trials), "Other" (26 trials), "Biological" (25 trials), "Procedure" (20 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Biospecimen Collection" (13 trials), "Quality-of-Life Assessment" (13 trials), "Computed Tomography" (12 trials), "Laboratory Biomarker Analysis" (9 trials) and "Magnetic Resonance Imaging" (9 trials). Other intervention names were less common.

The vast majority of trials in "Marjorie Weinberg Cancer Center at Loyola-Gottlieb" are 43 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Marjorie Weinberg Cancer Center at Loyola-Gottlieb". undefined are not yet recruiting, 20 are recruiting, 21 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Marjorie Weinberg Cancer Center at Loyola-Gottlieb, 3 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Marjorie Weinberg Cancer Center at Loyola-Gottlieb, 0 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".